Cancer drug major Fresenius Kabi Oncology Ltd, the Indian arm of Germany-based Fresenius Kabi, has withdrew revocation petitions against cancer drug patents owned by Pfizer and its subsidiaries as the former has "lost business interest" in the molecules. The ... Business Standard, 2 months ago
Human medicines European public assessment report (EPAR): Docetaxel Kabi, docetaxel, Revision: 5, Authorised
This is a summary of the European public assessment report (EPAR) for Docetaxel Kabi. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing ...European Medicines Agency, 1 month ago
The Ministry of Finance (MoF), Government of India , has cleared 20 foreign direct investment (FDI) proposals, including six in the pharmaceutical sector, envisaging a total inflow of Rs988.3 crore after approval by the Foreign Investment ...4 Traders, 3 weeks ago Govt approves 20 FDI proposals worth Rs 988.3 cr Hindu Business Line, 4 weeks ago FDI Proposals worth Rs 988 cr Approved New Indian Express, 3 weeks ago Finance Ministry clears 20 FDI proposals worth Rs 988 crore IndiaTV News, 3 weeks ago
The Government approved 20 Foreign Direct Investment proposals worth ₹988.3 crore and rejected five including Sistema Shyam Teleservices bid to raise foreign stake holding in the company to 100 per cent. The decisions have been taken based on a ...Hindu Business Line, 4 weeks ago
Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its meeting held on September 16, 2014, the Government has approved twenty (20) proposals of Foreign Direct Investment amounting to Rs. 988.3 crore approximately. Details ...Noodls, 4 weeks ago Ministry of Finance of Republic of India : Government approves Twenty (20) Proposals of Foreign Direct Investment amounting to Rs 988.3 Crore 4 Traders, 4 weeks ago
Regulatory experts stressed that the Indian pharma cos should put special focus on following all the data integrity requirements to avoid crackdown by regulatory agencies. This warning comes in the wake of growing incidence of issuance of letters by ...PharmaBiz, 2 months ago
on your WebpageAdd Widget >Get your members hooked!